Cancer immunoprevention

Current Opinion in Immunology
Olivera J Finn, Pamela L Beatty

Abstract

Cancer immunotherapy is now a reality. The results are phenomenal but the cost is outrageous. Even if the cost eventually comes down and immunotherapy becomes more broadly available, using the knowledge derived from immunotherapy to apply to immunoprevention would be a good strategy. The most likely approach to cancer immunoprevention is cancer vaccines. To date, cancer vaccines have been tested mostly in the setting of advanced disease. Numerous immunosuppressive mechanisms have been identified in the tumor microenvironment as well as systemically that compromise the ability of cancer patients to respond to the vaccines. Multiple approaches are being tested to improve therapeutic cancer vaccine efficacy, including combinations with other immunotherapies. An alternative approach is to administer the vaccines to individuals without cancer but at high risk for cancer. Data in support of this approach and immunoprevention in general is accumulating and clinical testing has started.

References

May 1, 1997·Journal of Clinical Pathology·Y AjiokaJ R Jass
Sep 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Madhav V DhodapkarKara Olson
Nov 26, 2003·The Journal of Experimental Medicine·Madhav V DhodapkarMatthew D Geller
Mar 23, 2004·Annual Review of Immunology·Gavin P DunnRobert D Schreiber
Jun 29, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David P CarboneJay A Berzofsky
Dec 1, 2006·Annual Review of Immunology·Gabriel A RabinovichEduardo M Sotomayor
Mar 29, 2007·The Journal of Experimental Medicine·Radek SpisekMadhav V Dhodapkar
Jan 3, 2008·Cancer Cell·Yves HüsemannChristoph A Klein
Sep 3, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Martin A CheeverLynn M Matrisian
Nov 6, 2009·The New England Journal of Medicine·Gemma G KenterCornelis J M Melief
Apr 21, 2010·Seminars in Immunology·Adam M Farkas, Olivera J Finn
Apr 27, 2010·Expert Opinion on Biological Therapy·Theresa L Whiteside
Dec 1, 2008·Gut and Liver·Suguru YonezawaMasamichi Goto
Apr 6, 2011·Cancer Immunology, Immunotherapy : CII·Sylvia AdamsAchim A Jungbluth
May 18, 2012·Current Pharmaceutical Design·Renee VermeijHans W Nijman
Jun 12, 2012·Cancer Immunology, Immunotherapy : CII·Peggy J de Vos van SteenwijkSjoerd H van der Burg
Jun 20, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Farhad AzimiJohn F Thompson
Sep 25, 2012·Expert Opinion on Biological Therapy·Takashi Kimura, Olivera J Finn
Dec 5, 2012·Vaccine·John T SchillerSuzanne M Garland
Jan 22, 2013·American Journal of Obstetrics and Gynecology·Krishna SinghOra Gordon
Jan 1, 2014·Liver International : Official Journal of the International Association for the Study of the Liver·Christian Trepo
May 27, 2014·Journal of Immunology Research·Liping DaiJian-Ying Zhang
Jul 30, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sylvia AdamsSunil S Badve
Aug 16, 2014·American Journal of Clinical Pathology·Renee FrankNirag C Jhala
Oct 17, 2014·Immunopharmacology and Immunotoxicology·Abid H BandayVictor J Hruby
Sep 1, 2015·Seminars in Oncology·Evan J LipsonSuzanne L Topalian
Oct 22, 2015·Expert Review of Vaccines·Xiao X WeiEric J Small
Nov 3, 2015·Biotechnology Advances·Lívia de Paula PeresMarcelo José Barbosa Silva

❮ Previous
Next ❯

Citations

Apr 9, 2016·Human Vaccines & Immunotherapeutics·Jon Oscherwitz
Sep 18, 2016·Proceedings of the National Academy of Sciences of the United States of America·Avrum SpiraScott M Lippman
Nov 2, 2016·Expert Opinion on Biological Therapy·Elham Beyranvand NejadSjoerd H van der Burg
Mar 23, 2017·Pharmacology & Therapeutics·Jason Lohmueller, Olivera J Finn
Dec 28, 2017·Nature Reviews. Immunology·Olivera J Finn
Aug 11, 2020·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Serge MoffettRené Roy
Jun 16, 2018·BMC Immunology·Arianna PalladiniPatrizia Nanni
Sep 29, 2017·Frontiers in Immunology·Melvin Kantono, Beichu Guo
Jun 6, 2018·Briefings in Bioinformatics·Francesco PappalardoMarco Viceconti
Apr 14, 2019·Cancers·Carla De GiovanniPier-Luigi Lollini
Oct 13, 2018·Journal of the National Cancer Institute·Tsuyoshi HamadaShuji Ogino
Mar 28, 2020·Molecular Carcinogenesis·Hang RuanJian Yu
Oct 10, 2020·Journal of Cancer Prevention·Kyle J Gu, Guojun Li
May 4, 2017·Cancer Immunology Research·Olivera J Finn
Jan 10, 2021·Cancers·Maria Adamaki, Vassilios Zoumpourlis
Oct 28, 2019·Molecular Therapy Oncolytics·Xiaoming ZhongZhiwen Yang
Dec 3, 2020·Critical Reviews in Oncology/hematology·Leila JafarzadehHamid Reza Mirzaei
Mar 13, 2021·Advanced Drug Delivery Reviews·Carina PeresHelena F Florindo
Mar 30, 2021·Signal Transduction and Targeted Therapy·Pian YuXiang Chen
May 21, 2021·Virus Research·Diego C CarneiroJoana P Monteiro-Cunha
Jun 15, 2021·Current Oncology Reports·Danielle M Pastor, Jeffrey Schlom
Jul 31, 2021·Acta Biomaterialia·Xuan ZhangWenjun Shan
Aug 4, 2021·Cancer Prevention Research·Kristin WallaceAlexander V Alekseyenko

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

© 2022 Meta ULC. All rights reserved